| Company Name: |
J & K SCIENTIFIC LTD.
|
| Tel: |
18210857532 |
| Email: |
jkinfo@jkchemical.com |
| Products Intro: |
Product Name:Ioxilan
CAS:107793-72-6
Package:10Mg,1Mg
|
| Company Name: |
Chemsky (shanghai) International Co.,Ltd
|
| Tel: |
021-50135380 |
| Email: |
shchemsky@sina.com |
| Products Intro: |
Product Name:Ioxilan;5-[Acetyl(2,3-dihydroxypropyl)aMino]-N1-(2,3-dihydroxypropyl)-N3-(2-hydroxyethyl)-2,4,6-triiodo-1,3-benzenedicarboxaMide;
CAS:107793-72-6
Purity:98+% Package:1Mg;5Mg;10Mg;50Mg;100Mg;500Mg
|
| Company Name: |
Sinopharm Chemical Reagent Co,Ltd.
|
| Tel: |
86-21-63210123 |
| Email: |
sj_scrc@sinopharm.com |
| Products Intro: |
Product Name:Ioxilan (400 mg)
CAS:107793-72-6
Package:400 mg
|
|
| | IOXILAN (400 MG) Basic information |
| Product Name: | IOXILAN (400 MG) | | Synonyms: | IOXILAN (400 MG);5-[Acetyl(2,3-dihydroxypropyl)aMino]-N1-(2,3-dihydroxypropyl)-N3-(2-hydroxyethyl)-2,4,6-triiodo-1,3-benzenedicarboxaMide;1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N-(2,3-dihydroxypropyl)-N'-(2-hydroxyethyl)-2,4,6-triiodo-;Ioxitol;Oxilan 300;5-[acetyl(2,3-dihydroxypropyl)amino]-3-N-(2,3-dihydroxypropyl)-1-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide;1,3-Benzenedicarboxamide, 5-[acetyl(2,3-dihydroxypropyl)amino]-N1-(2,3-dihydroxypropyl)-N3-(2-hydroxyethyl)-2,4,6-triiodo-;Ioxilan (1345206) | | CAS: | 107793-72-6 | | MF: | C18H24I3N3O8 | | MW: | 791.11 | | EINECS: | | | Product Categories: | Amines;Aromatics;Diagnostic;Intermediates & Fine Chemicals;Pharmaceuticals | | Mol File: | 107793-72-6.mol |  |
| | IOXILAN (400 MG) Chemical Properties |
| | IOXILAN (400 MG) Usage And Synthesis |
| Uses | Nonionic iodinated contrast medium. Diagnostic aid (radiopaque medium). | | Definition | ChEBI: Ioxilan is an amidobenzoic acid. | | Brand name | Oxilan (Guerbet). | | in vivo | Rapid intravenous injection of water-soluble X-ray contrast agents (Ioxilan) can be performed with dynamic computed tomography to improve the detectability of liver lesions. When injected intravenously, water-soluble, intravenous X-ray contrast agents are largely distributed in the extracellular fluid space and excreted unchanged by the kidneys. Contrast enhancement of a region of interest depends on the route of administration, delivery of the agent to the area by blood flow, and the final iodine concentration in the region[1]. |
| | IOXILAN (400 MG) Preparation Products And Raw materials |
|